Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists | Patent Number 08921348

US 08921348 B2
Application Number14065792
Publication NumberUS 20140162993 A1
Pendency1 year, 2 months, 2 days
Filled DateOct 29, 2013
Priority DateAug 30, 2007
Publication DateJun 12, 2014
Expiration DateAug 29, 2027
Inventor/ApplicantsJoseph K. Belanoff
ExaminesHUI, SAN MING R
Art Unit1621
Technology Center1600
Assignments
Corcept Therapeutics
Current
Corcept Therapeutics
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.